US Stock MarketDetailed Quotes

TCDAQ TRICIDA INC

Watchlist
  • 0.000010
  • 0.0000000.00%
15min DelayClose Jun 13 16:00 ET
580.28Market Cap0.00P/E (TTM)

About TRICIDA INC Company

Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.

Company Profile

SymbolTCDAQ
Company NameTRICIDA INC
CEODr. Gerrit Klaerner, PhD.
MarketPink Market
Employees57
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.tricida.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gerrit Klaerner, PhD.
  • Director, President and Chief Executive Officer
  • 4.68M
  • Robert McKague
  • Executive Vice President, General Counsel and Chief Compliance Officer
  • 2.43M
  • Annie Yoshiyama
  • Vice President, Finance and Chief Accounting Officer
  • --
  • Geoffrey M. Parker
  • Chief Operating Officer, Chief Financial Officer and Executive Vice President
  • 2.51M
  • Dr. Dawn Parsell
  • Executive Vice President, Clinical Development
  • 2.77M
  • Dr. Klaus Veitinger, M.D.,PhD
  • Chairman of the Board
  • 379.00K
  • Thomas G. FitzGerald
  • Independent Director
  • --
  • Kathryn E. Falberg
  • Independent Director
  • 329.00K
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 339.00K
  • Dr. Robert J. Alpern,M.D.
  • Independent Director
  • 314.00K
  • Dr. David Hirsch, M.D.,PhD
  • Independent Director
  • 326.50K
  • Sandra I Coufal
  • Independent Director
  • 316.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg